Press Enter to Main Content
您的瀏覽器似乎不支援JavaScript語法,但沒關係,這裡的JavaScript語法並不會影響到內容的陳述, 如需要選擇字級大小,IE6請利用鍵盤按住ALT鍵+ V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小, 而IE7或Firefox瀏覽器則可利用鍵盤 Ctrl + (+)放大(-)縮小來改變字型大小,如需要回到上一頁可使用瀏覽器提供的 Alt+左方向鍵(←) 快速鍵功能,列印可使用瀏覽器提供的(Ctrl+P)功能。
  • facebook
  • line
  • twitter
  • Print
  • Back

Taiwan FDA holds the “Conference on International Medical Device Regulation in South Asia”

  • Data Source:Food and Drug Administration, Ministry of Health and Welfare
  • Created:2018-09-06
  • Last Updated:2018-10-16

To understand the development trends in international medical device regulation, promote the regulatory harmonization with advanced countries, and assist the domestic industry in entering global market, Taiwan Food and Drug Administration (TFDA) holds the “Conference on International Medical Device Regulation in South Asia” on September 6, 2018, at NTUH International Convention Center’s Room 101. It is estimated that approximately 340 participants from the industry groups, regulatory bodies, academic institutions, and research organizations has joined the conference.

In this conference, TFDA invites experts knowledgeable in Vietnam, Philippines, India, and Indonesia regulations to be speakers for introducing the latest regulatory status of medical devices in these countries. It is hoped that this will help domestic manufacturers to better understand medical device regulations of other countries, and thus enhance the international cooperation and marketing, as well as strengthen the competitiveness in global market for Taiwan industry. 

TFDA has been promoting the New Southbound Policy implemented by the Executive Yuan since 2016. It is anticipated that by utilizing the advantages of Taiwan’s soft power in medical field, a beneficial foundation can be established for strengthening the international partnerships between Taiwan and the New Southbound countries, thereby achieving bilateral and multilateral cooperation with ASEAN, South Asia, New Zealand and Australia, as well as creating regional development and prosperity.

At the time when the legislative procedure of Taiwan’s Medical Devices Act is being promoted by TFDA, ASEAN and India are also implementing regulatory innovations during the same period. Through interactions with New Southbound countries in this conference, experiences may be mutually shared and the capacity of regulatory exchange between Taiwan and New Southbound countries may be further enhanced. This will also assist Taiwan’s medical device industry to learn about the latest implications of their medical device regulations, further understand regulatory changes, and help manufacturers to export and sell products to the international market.